1. Home
  2. SSYS vs MLYS Comparison

SSYS vs MLYS Comparison

Compare SSYS & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSYS
  • MLYS
  • Stock Information
  • Founded
  • SSYS 1989
  • MLYS 2019
  • Country
  • SSYS United States
  • MLYS United States
  • Employees
  • SSYS 1980
  • MLYS N/A
  • Industry
  • SSYS Computer peripheral equipment
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SSYS Technology
  • MLYS Health Care
  • Exchange
  • SSYS Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • SSYS 534.6M
  • MLYS 590.3M
  • IPO Year
  • SSYS 1994
  • MLYS 2023
  • Fundamental
  • Price
  • SSYS $7.31
  • MLYS $13.80
  • Analyst Decision
  • SSYS Strong Buy
  • MLYS Strong Buy
  • Analyst Count
  • SSYS 4
  • MLYS 2
  • Target Price
  • SSYS $10.75
  • MLYS $30.00
  • AVG Volume (30 Days)
  • SSYS 388.7K
  • MLYS 120.9K
  • Earning Date
  • SSYS 11-14-2024
  • MLYS 11-05-2024
  • Dividend Yield
  • SSYS N/A
  • MLYS N/A
  • EPS Growth
  • SSYS N/A
  • MLYS N/A
  • EPS
  • SSYS N/A
  • MLYS N/A
  • Revenue
  • SSYS $600,561,000.00
  • MLYS N/A
  • Revenue This Year
  • SSYS N/A
  • MLYS N/A
  • Revenue Next Year
  • SSYS $4.53
  • MLYS N/A
  • P/E Ratio
  • SSYS N/A
  • MLYS N/A
  • Revenue Growth
  • SSYS N/A
  • MLYS N/A
  • 52 Week Low
  • SSYS $6.05
  • MLYS $5.85
  • 52 Week High
  • SSYS $14.93
  • MLYS $16.91
  • Technical
  • Relative Strength Index (RSI)
  • SSYS 51.28
  • MLYS 57.09
  • Support Level
  • SSYS $6.92
  • MLYS $13.34
  • Resistance Level
  • SSYS $8.11
  • MLYS $14.05
  • Average True Range (ATR)
  • SSYS 0.29
  • MLYS 0.47
  • MACD
  • SSYS 0.00
  • MLYS -0.06
  • Stochastic Oscillator
  • SSYS 49.58
  • MLYS 42.28

About SSYS Stratasys Ltd. (Israel)

Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

Share on Social Networks: